FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008122005> ?p ?o ?g. }

• W2008122005 endingPage "812" @default.
• W2008122005 startingPage "809" @default.
• W2008122005 abstract "ThyroidVol. 18, No. 7 Letters to the EditorSunitinib-Associated Lymphocytic Thyroiditis without Circulating Antithyroid AntibodiesDoru T. Alexandrescu, Geanina Popoveniuc, Haleh Farzanmehr, Constantin A. Dasanu, Nancy Dawson, and Leonard WartofskyDoru T. AlexandrescuSearch for more papers by this author, Geanina PopoveniucSearch for more papers by this author, Haleh FarzanmehrSearch for more papers by this author, Constantin A. DasanuSearch for more papers by this author, Nancy DawsonSearch for more papers by this author, and Leonard WartofskySearch for more papers by this authorPublished Online:16 Jul 2008https://doi.org/10.1089/thy.2007.0349AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByThyroid disorders in programmed death 1 inhibitor‐treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?1 January 2020 | Clinical Endocrinology, Vol. 92, No. 3“Thyroid disfunction induced by sunitinb treatment in oncological patients”15 November 2018 | Endocrinology&Metabolism International Journal, Vol. 6, No. 6Disfunzioni tiroidee in pazienti con tumori solidi trattati con farmaci inibitori delle tirosino-chinasi27 November 2017 | L'Endocrinologo, Vol. 18, No. 6Role of Sunitinib-Induced Hypothyroidism in Oncological Patients27 September 2017 | Endocrinology&Metabolism International Journal, Vol. 5, No. 4Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma27 March 2017 | International Cancer Conference Journal, Vol. 6, No. 3Inhibidores de tirosina cinasa y disfunción tiroideaRevista Argentina de Endocrinología y Metabolismo, Vol. 53, No. 3Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?30 May 2016 | Journal of Chemotherapy, Vol. 28, No. 3Endocrine and Metabolic Emergencies14 May 2016Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved? Fabiana Pani, Francesco Atzori, Germana Baghino, Francesco Boi, Luciana Tanca, Maria Teresa Ionta, and Stefano Mariotti6 November 2015 | Thyroid, Vol. 25, No. 11Dysthyroidie sous anti-VEGF, effet indésirable de classe ? À propos d’un casTherapies, Vol. 69, No. 6Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis13 June 2014 | Expert Review of Anticancer Therapy, Vol. 14, No. 9Cabozantinib-Induced Thyroid Dysfunction: A Review of Two Ongoing Trials for Metastatic Bladder Cancer and Sarcoma Sahzene Yavuz, Andrea B. Apolo, Shivaani Kummar, Jaydira del Rivero, Ravi A. Madan, Thomas Shawker, James Reynolds, and Francesco S. Celi22 July 2014 | Thyroid, Vol. 24, No. 8Treatment With Thyroid Hormone16 January 2014 | Endocrine Reviews, Vol. 35, No. 3Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs Francesco Torino, Agnese Barnabei, Rosamaria Paragliola, Roberto Baldelli, Marialuisa Appetecchia, and Salvatore Maria Corsello6 November 2013 | Thyroid, Vol. 23, No. 11Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinomaEndocrine-Related Cancer, Vol. 20, No. 5The Effect of Medications on Thyroid Function TestsMedical Clinics of North America, Vol. 96, No. 2Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?Annals of Oncology, Vol. 23, No. 3Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case ReportChemotherapy, Vol. 58, No. 2Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management19 November 2011 | Targeted Oncology, Vol. 6, No. 4Thyroid Dysfunction from Antineoplastic Agents18 October 2011 | JNCI Journal of the National Cancer Institute, Vol. 103, No. 21A CT Scan Aspect of “Hypodense Thyroid Gland” after Sunitinib Treatment for Metastatic Carcinoma of the KidneyThe Journal of Clinical Endocrinology & Metabolism, Vol. 96, No. 3Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 DeiodinationThe Journal of Clinical Endocrinology & Metabolism, Vol. 95, No. 8Shrinkage of Thyroid Volume in Sunitinib-Treated Patients with Renal-Cell Carcinoma: A Potential Marker of Irreversible Thyroid Dysfunction? Aljosja Rogiers, Pascal Wolter, Katya Op de Beeck, Marleen Thijs, Brigitte Decallonne, and Patrick Schöffski28 February 2010 | Thyroid, Vol. 20, No. 3How Does Sunitinib Cause Hypothyroidism? Jerome M. Hershman and Llanyee Liwanpo28 February 2010 | Thyroid, Vol. 20, No. 3Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinomaEndocrine Journal, Vol. 57, No. 10Sunitinib-Induced Thyrotoxicosis Followed by Persistent Hypothyroidism with Shrinkage of Thyroid VolumeThe Tohoku Journal of Experimental Medicine, Vol. 222, No. 1Autoimmunity and Thyroid Dysfunction During Sunitinib Treatment in Metastatic Renal Cell CarcinomaThe Endocrinologist, Vol. 19, No. 5 Volume 18Issue 7Jul 2008 InformationCopyright 2008, Mary Ann Liebert, Inc.To cite this article:Doru T. Alexandrescu, Geanina Popoveniuc, Haleh Farzanmehr, Constantin A. Dasanu, Nancy Dawson, and Leonard Wartofsky.Sunitinib-Associated Lymphocytic Thyroiditis without Circulating Antithyroid Antibodies.Thyroid.Jul 2008.809-812.http://doi.org/10.1089/thy.2007.0349Published in Volume: 18 Issue 7: July 16, 2008PDF download" @default.
• W2008122005 created "2016-06-24" @default.
• W2008122005 creator A5001190634 @default.
• W2008122005 creator A5004080743 @default.
• W2008122005 creator A5026179839 @default.
• W2008122005 creator A5044346365 @default.
• W2008122005 creator A5047084959 @default.
• W2008122005 creator A5068461585 @default.
• W2008122005 date "2008-07-01" @default.
• W2008122005 modified "2023-09-26" @default.
• W2008122005 title "Sunitinib-Associated Lymphocytic Thyroiditis without Circulating Antithyroid Antibodies" @default.
• W2008122005 cites W1999365970 @default.
• W2008122005 cites W2003943009 @default.
• W2008122005 cites W2051963942 @default.
• W2008122005 cites W2052303068 @default.
• W2008122005 cites W2097535250 @default.
• W2008122005 cites W2097597413 @default.
• W2008122005 cites W2113788015 @default.
• W2008122005 cites W2132272301 @default.
• W2008122005 cites W2149032069 @default.
• W2008122005 cites W2149267995 @default.
• W2008122005 cites W2153331460 @default.
• W2008122005 cites W2154117685 @default.
• W2008122005 cites W2198326490 @default.
• W2008122005 cites W2268496182 @default.
• W2008122005 doi "https://doi.org/10.1089/thy.2007.0349" @default.
• W2008122005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18631016" @default.
• W2008122005 hasPublicationYear "2008" @default.
• W2008122005 type Work @default.
• W2008122005 sameAs 2008122005 @default.
• W2008122005 citedByCount "29" @default.
• W2008122005 countsByYear W20081220052012 @default.
• W2008122005 countsByYear W20081220052013 @default.
• W2008122005 countsByYear W20081220052014 @default.
• W2008122005 countsByYear W20081220052015 @default.
• W2008122005 countsByYear W20081220052016 @default.
• W2008122005 countsByYear W20081220052017 @default.
• W2008122005 countsByYear W20081220052020 @default.
• W2008122005 crossrefType "journal-article" @default.
• W2008122005 hasAuthorship W2008122005A5001190634 @default.
• W2008122005 hasAuthorship W2008122005A5004080743 @default.
• W2008122005 hasAuthorship W2008122005A5026179839 @default.
• W2008122005 hasAuthorship W2008122005A5044346365 @default.
• W2008122005 hasAuthorship W2008122005A5047084959 @default.
• W2008122005 hasAuthorship W2008122005A5068461585 @default.
• W2008122005 hasConcept C126322002 @default.
• W2008122005 hasConcept C134018914 @default.
• W2008122005 hasConcept C143998085 @default.
• W2008122005 hasConcept C2777472916 @default.
• W2008122005 hasConcept C2778439243 @default.
• W2008122005 hasConcept C2778696486 @default.
• W2008122005 hasConcept C2779490328 @default.
• W2008122005 hasConcept C526584372 @default.
• W2008122005 hasConcept C71924100 @default.
• W2008122005 hasConceptScore W2008122005C126322002 @default.
• W2008122005 hasConceptScore W2008122005C134018914 @default.
• W2008122005 hasConceptScore W2008122005C143998085 @default.
• W2008122005 hasConceptScore W2008122005C2777472916 @default.
• W2008122005 hasConceptScore W2008122005C2778439243 @default.
• W2008122005 hasConceptScore W2008122005C2778696486 @default.
• W2008122005 hasConceptScore W2008122005C2779490328 @default.
• W2008122005 hasConceptScore W2008122005C526584372 @default.
• W2008122005 hasConceptScore W2008122005C71924100 @default.
• W2008122005 hasIssue "7" @default.
• W2008122005 hasLocation W20081220051 @default.
• W2008122005 hasLocation W20081220052 @default.
• W2008122005 hasOpenAccess W2008122005 @default.
• W2008122005 hasPrimaryLocation W20081220051 @default.
• W2008122005 hasRelatedWork W2154171266 @default.
• W2008122005 hasRelatedWork W2254527377 @default.
• W2008122005 hasRelatedWork W2557225468 @default.
• W2008122005 hasRelatedWork W2748952813 @default.
• W2008122005 hasRelatedWork W2767323531 @default.
• W2008122005 hasRelatedWork W3087328364 @default.
• W2008122005 hasRelatedWork W3202900078 @default.
• W2008122005 hasRelatedWork W4240019515 @default.
• W2008122005 hasRelatedWork W4244202974 @default.
• W2008122005 hasRelatedWork W4311401312 @default.
• W2008122005 hasVolume "18" @default.
• W2008122005 isParatext "false" @default.
• W2008122005 isRetracted "false" @default.
• W2008122005 magId "2008122005" @default.
• W2008122005 workType "article" @default.